SG Americas Securities’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-44,200
| Closed | -$3.19M | – | 3696 |
|
|
2020
Q4 | $3.19M | Buy |
44,200
+37,668
| +577% | +$1.97M | 0.02% | 783 |
|
|
2020
Q3 | $298K | Sell |
6,532
-14,605
| -69% | -$611K | ﹤0.01% | 1943 |
|
|
2020
Q2 | $955K | Sell |
21,137
-6,779
| -24% | -$304K | 0.01% | 1459 |
|
|
2020
Q1 | $1.07M | Buy |
27,916
+17,014
| +156% | +$783K | 0.01% | 1236 |
|
|
2019
Q4 | $505K | Buy |
10,902
+2,797
| +35% | +$121K | ﹤0.01% | 1772 |
|
|
2019
Q3 | $330K | Sell |
8,105
-9,319
| -53% | -$402K | ﹤0.01% | 2106 |
|
|
2019
Q2 | $839K | Sell |
17,424
-7,521
| -30% | -$395K | 0.01% | 1548 |
|
|
2019
Q1 | $1.56M | Sell |
24,945
-20,096
| -45% | -$1.38M | 0.01% | 1001 |
|
|
2018
Q4 | $2.69M | Buy |
45,041
+42,793
| +1,904% | +$2.57M | 0.02% | 676 |
|
|
2018
Q3 | $145K | Buy |
+2,248
| New | +$125K | ﹤0.01% | 2708 |
|
|
2016
Q4 | – | Sell |
-6,584
| Closed | -$122K | – | 3732 |
|
|
2016
Q3 | $122K | Buy |
+6,584
| New | +$124K | ﹤0.01% | 2910 |
|
|
2014
Q3 | – | Sell |
-34,774
| Closed | -$249K | – | 3033 |
|
|
2014
Q2 | $249K | Buy |
+34,774
| New | +$277K | ﹤0.01% | 1930 |
|
Other funds holding BEAT
SG Americas Securities's BEAT Position: Q1 2021 in Review
SG Americas Securities sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 44,200 shares — an estimated $3.19M sold.
SG Americas Securities first reported a position in BEAT in Q2 2014 and held it in 12 quarters. The position peaked at $3.19M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- SG Americas Securities reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- SG Americas Securities sold 44,200 BioTelemetry, Inc. shares in Q1 2021, an estimated $3.19M.
- SG Americas Securities first reported a position in BioTelemetry, Inc. in Q2 2014 and held it in 12 quarters.
- SG Americas Securities's BioTelemetry, Inc. position peaked at $3.19M in Q4 2020.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on SG Americas Securities's 13F filing for Q1 2021, filed 13 May 2021.